HCMC – Roche Pharma Vietnam and the University Medical Center HCMC on July 13 signed a memorandum of understanding (MOU) to improve cancer control and treatment capacity.
The event marks a comprehensive partnership between the two sides to enable cancer patients to access advanced therapies.
The cooperation includes improving the capacity and knowledge of medical staff in diagnosis, treatment and care for cancer patients; connecting, integrating, and participating in cooperation activities with domestic and international agencies and organizations in the field of oncology.
It also allows the two sides to implement patient and community-oriented activities, develop and implement the liver cancer project and conduct research to collect data for treatment and patient care.
“Every year, University Medical Center HCMC receives and treats many patients with different cancer diseases. Therefore, we hope that the cooperation between the hospital and Roche Pharma Vietnam will help bring about treatment efficiency, and benefit patients,” said Prof. Dr. Truong Quang Binh, deputy director of the University Medical Center HCMC.
Lennor Carrilo, general director of Roche Pharma Vietnam, said as a global pioneer in the pharmaceutical industry, Roche strives to give cancer patients more opportunities to access advanced therapies, easing the financial burden on patients, their families, the medical industry and society.
“The expansion of cooperation with leading hospital partners across the country is a positive significance to improve the healthcare system, strengthen medical examination and treatment capacity for medical staff in the field of oncology and improve the quality of life of patients,” Carrilo said.
Roche Vietnam has also cooperated with the HCMC Association of Family Physicians to operate the website https://buoctiep.vn/.
The website aims to help patients and their relatives access more verified information on diagnosis, care and timely treatment. Therefore, the community will raise their awareness and understanding of cancer and rare diseases, and reduce the healthcare burden of these diseases.
According to Globocan data (2020), Vietnam ranked 90 out of 185 countries in new cancer incidence rates as the cases rose from 165,000 in 2018 to 182,000 in 2020, with the most common cancer being liver cancer (14.5%), followed by lung cancer (14.4%), breast cancer (11.8%), stomach cancer (9.8%), and colorectal cancer (8.6%).
